Home | Infections | Hepatitis


Two genes linked to postpartum immunity revival in women with persistent hepatitis C

Research may provide a model for identifying immune factors needed to control chronic infections ...

Over 1 million treated with highly effective hepatitis C medicines

High prices–a major barrier to access ...

New study launched to discover how “super” immune system can prevent hepatitis c

The scientists will seek the genetic basis for resistance to the virus (HCV). They invite all women who received HCV-contaminated anti-D in 1977-79 to volunteer. ... Full story

UNC researchers identify how hepatitis A virus causes liver injury

A new report in the journal Science describes how the virus can jump species, including to mice – a finding that has major implications for researching the disease and host immune responses to the virus. Jason Whitmire, PhD, and Stanley Lemon, MD, led the research team. ... Full story

Get tested, get treated, Hep C researchers urge

Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say ... Full story

Digital reminders boost hepatitis C screening among baby boomers

Strategy helps high-risk group get tested for hepatitis C ... Full story

New hepatitis C virus mechanism elucidated

A group of researchers led by Assistant Professor OKAMOTO Toru and Professor MATSUURA Yoshiharu of the Research Institute for Microbial Diseases, Osaka University identified a new drug target capable of suppressing the propagation of the hepatitis C virus (HCV), improving HCV pathologic conditions, and discovering its drug efficacy. HCV, a main cause of viral liver cancer, accounts for 70 percent of all liver cancers in Japan. There are about 200 million HCV-infected people in the world. Once infected, people develop fatty liver, hepatic fibrosis, and liver cancer. ... Full story

Erasing hepatitis C: Is Canada doing enough?

More work needed to screen baby boomers at higher risk of carrying the disease, ensure antiviral drugs reach patients, say UAlberta researchers. ... Full story

WHO encourages countries to act now to reduce deaths from viral hepatitis

GENEVA - Ahead of World Hepatitis Day, 28 July 2016, WHO is urging countries to take rapid action to improve knowledge about the disease, and to increase access to testing and treatment services. Today, only 1 in 20 people with viral hepatitis know they have it. And just 1 in 100 with the disease is being treated. ... Full story

Tricks of Ticking time bomb Hepatitis B Virus

Hepatitis B virus (HBV) causes hepatitis B, an infectious disease that afflicts 230 million people worldwide, thereof 440 000 in Germany. Persistence of the virus in liver cells leads to progressive organ damage in the patient and contributes to a high risk of cirrhosis and liver cancer development. Providing a new paradigm to hepatitis B understanding, researchers at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, and Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital have now uncovered a novel maturation mechanism employed by HBV to improve its infection success. Their findings are reported in the newest issue of Cell Host & Microbe. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 116 | displaying: 1 - 10